Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDCC Regulatory News (DCC)

Share Price Information for DCC (DCC)

Share Price is delayed by 15 minutes
Get Live Data
6,025.00    45.00 (0.75%)
Bid:
6,020.00
Ask:
6,030.00
Spread: 10.00 (0.166%)
Market Cap: £5.15b
DCC Live PriceLast checked at - London Stock Exchange

Intraday DCC Share Chart

RULE 38.5_A - DCC Plc

1 May 2026 10:02

RNS Number : 8010C
Morgan Stanley Europe SE
01 May 2026
 

 

FORM 38.5(a) (EPT/RI)

 

IRISH TAKEOVER PANEL

 

DEALING DISCLOSURE UNDER RULE 38.5(a) OF THE IRISHTAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022BY A CONNECTED EXEMPT PRINCIPAL TRADER WITHRECOGNISED INTERMEDIARY STATUS AND DEALING INA CLIENT-SERVING CAPACITY

 

1. KEY INFORMATION

 

 

(a) Name of exempt principal trader:

Morgan Stanley Europe SE

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

DCC Plc

(c) Name of the party to the offer with which exempt principal trader is connected: (Note 1)

Energy Capital Partners, LLC and Kohlberg Kravis Roberts & Co. L.P

(d) Date dealing undertaken:

30 April 2026

(e) In addition to the company in 1(b) above, is the exempt principal trader also making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER (Note 2)

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

 

 

(a) Purchases and sales

 

Class of relevant security (Note 3)

Purchases/ sales

Totalnumber of securities

Highest price per unit paid/ received

Lowest price per unit paid/ received

0.25 ordinary shares

PURCHASES

10,672

57.8483 GBP

55.4000 GBP

0.25 ordinary shares

SALES

10,672

57.3850 GBP

55.4000 GBP

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description e.g. CFD

Nature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities (Note 4)

Price perunit (Note 5)

N/A

N/A

N/A

N/A

N/A

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates (Note 4)

Exercise price per unit

Type  e.g. American, European etc.

Expirydate

Option money paid/ received per unit

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

 

(ii) Exercise

 

Class of relevant security

Product description e.g. call option

Exercising/ exercised against

Number of securities

Exercise priceper unit (Note 5)

N/A

N/A

N/A

N/A

N/A

 

(d) Other dealings (including transactions in respect of new securities)

 

Class of relevant security

Nature of dealing e.g. subscription, conversion, exercise

Details

Price per unit (if applicable) (Note 5)

N/A

N/A

N/A

N/A

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

 

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

NONE

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

NONE

 

Date of disclosure:

01 May 2026

Contact name:

Claire Gordon

Telephone number:

+44 141 245-8893

 

Public disclosures under Rule 38 of the Rules must be made to a Regulatory Information Service.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ITPUARKRNAUVRRR
Date   Source Headline
23rd Dec 20254:43 pmRNSHolding in Company TR-1
23rd Dec 20254:43 pmRNSHolding in Company TR-1
23rd Dec 202512:55 pmRNSHolding in Company TR-1
23rd Dec 202512:55 pmRNSHolding in Company TR-1
19th Dec 20256:00 pmRNSDCC
19th Dec 20256:00 pmRNSDCC
19th Dec 202512:55 pmRNSAcquisition of Shares under Tender Offer and TVR
19th Dec 202512:55 pmRNSAcquisition of Shares under Tender Offer and TVR
19th Dec 20257:00 amRNSResults of Tender Offer
19th Dec 20257:00 amRNSResults of Tender Offer
18th Dec 20255:46 pmRNSHolding in Company TR-1
18th Dec 20255:46 pmRNSHolding in Company TR-1
17th Dec 20253:46 pmRNSHolding in Company TR-1
15th Dec 20255:01 pmRNSHolding in Company TR-1
11th Dec 20252:40 pmRNSResult of Extraordinary General Meeting
10th Dec 20254:46 pmRNSHolding in Company TR-1
5th Dec 20252:29 pmRNSHolding in Company TR-1
5th Dec 20252:16 pmRNSHolding in Company TR-1
2nd Dec 20256:13 pmRNSHolding in Company TR-1
28th Nov 20256:11 pmRNSTotal Voting Rights
28th Nov 20254:52 pmRNSHolding in Company TR-1
28th Nov 20251:07 pmRNSHolding in Company TR-1
26th Nov 20254:37 pmRNSHolding in Company TR-1
26th Nov 20259:46 amRNSHolding in Company TR-1
25th Nov 20254:36 pmRNSHolding in Company TR-1
24th Nov 20255:26 pmRNSHolding in Company TR-1
21st Nov 20255:36 pmRNSHolding in Company TR-1
19th Nov 202510:16 amRNSHolding in Company TR-1
18th Nov 20256:05 pmRNSHolding in Company TR-1
17th Nov 20257:00 amRNSProposed return of up to £600m by tender offer
13th Nov 20255:55 pmRNSDirector/PDMR Shareholding
11th Nov 20257:00 amRNSResults for the six months ended 30 September 2025
3rd Nov 20257:00 amRNSCompletion of sale of Info Tech business
21st Oct 202512:30 pmRNSLiquid Gas Acquisitions
17th Oct 20259:50 amRNSHolding in Company TR-1
17th Oct 20257:00 amRNSDirector Declaration
15th Oct 20253:38 pmRNSHolding in Company TR-1
13th Oct 202512:45 pmRNSHolding in Company TR-1
7th Oct 20252:00 pmRNSHolding in Company TR-1
3rd Oct 20254:30 pmRNSHolding in Company TR-1
1st Oct 202512:43 pmRNSHolding in Company TR-1
25th Sep 20254:02 pmRNSHolding in Company TR-1
22nd Sep 20256:09 pmRNSHolding in Company TR-1
22nd Sep 202511:20 amRNSHolding in Company TR-1
12th Sep 20257:00 amRNSTransaction in Own Shares
11th Sep 20257:00 amRNSTransaction in Own Shares
10th Sep 20257:00 amRNSTransaction in Own Shares
10th Sep 20257:00 amRNSDCC Healthcare sale completes and capital return
9th Sep 20257:00 amRNSTransaction in Own Shares
8th Sep 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.